MANSOUR, A., THOMPSON, R. C., AKIL, H. AND WATSON, S. J.: Delta opioid receptor
mRNA distribution in the brain: Comparison to delta receptor binding and
proenkephalin mRNA. J. Chem. Neuroanat. 6: 351–362, 1993.
OLDENDORF, W. H., HYMAN, S., BRAUN, L. AND OLDENDORF, S. Z.: Blood-brain
barrier: penetration of morphine, codeine, heroin, and methadone after
carotid injection. Science 178: 984–986, 1972.
PARROTT, R. F. AND GOODE, J. A.: Effects of intracerebroventricular corticotropin-releasing hormone and intravenous morphine on cortisol, prolactin and
growth hormone secretion in sheep. Domest. Anim. Endocrinol. 9: 141–149,
1992.
PARROTT, R. F. AND GOODE, J. A.: Central effects of naloxone and selected opioid
agonists on cortisol and prolactin secretion in non-stressed sheep. Gen.
Pharmacol. 24: 101–103, 1993.
PARROTT, R. F. AND THORNTON, S. N.: Opioid influences on pituitary function in
sheep under basal conditions and during psychological stress. Psychoneuroendocrinology 14: 451–459, 1989.
PECHNICK, R. N.: Effects of opioids on the hypothalamo-pituitary-adrenal axis.
Annu. Rev. Pharmacol. Toxicol. 33: 353–382, 1993.
PETRILLO, P., TAVANI, A., VEROTTA, D., ROBSON, L. E. AND KOSTERLITZ, H. W.:
Differential postnatal development of mu-, delta- and kappa-opioid binding
sites in rat brain. Brain Res. 428: 53–58, 1987.
PFEIFFER, A., HERZ, A., LORIAUX, D. L. AND PFEIFFER, D. G.: Central kappa- and
mu-opiate receptors mediate ACTH-release in rats. Endocrinology 116:
2688–2690, 1985.
PFEIFFER, A., PASI, A., MEHRAEIN, W. AND HERZ, A.: Opiate binding sites in
human brain. Brain Res. 248: 87–96, 1982.
PINSKY, C., LABELLA, F., HAVLICEK, V. AND DUA, A. K.: Apparent central agonist
actions of naloxone in the unrestrained rat. In Characteristics and Function
of Opioids, ed. by J. M. Van Ree and L. Terenius, pp. 439–440, Elsevier/
North Holland, Amsterdam, 1978.
QI, J. A., HEYMAN, J. S., SHELDON, R. J., KOSLO, R. J. AND PORRECA, F.: Mu
antagonist and kappa agonist properties of beta-funaltrexamine (beta-FNA)
in vivo: Long-lasting spinal analgesia in mice. J. Pharmacol. Exp. Ther. 252:
1006–1011, 1990.
REDEKOPP, C. A., LIVESEY, J. H. AND DONALD, R. A.: Inhibition of spontaneous
ACTH release and improved response to CRF in sheep premedicated with
the enkephalin analogue DAMME. Horm. Metab. Res. 17: 646–649, 1985.
ROSSI, N. F. AND BROOKS, D. P.: kappa-Opioid agonist inhibition of osmotically
induced AVP release: Preferential action at hypothalamic sites. Am. J.
Physiol. Endocrinol. Metab. 270: E367–E372, 1996.
SPAIN, J. W., ROTH, B. L. AND COSCIA, C. J.: Differential ontogeny of multiple
opioid receptors (μ, d, and k). J. Neurosci. 5: 584–588, 1985.
SZETO, H. H.: Morphine-induced activation of fetal EEG is mediated via central
muscarinic pathways. Am. J. Physiol. 260: R509–R517, 1991.
SZETO, H. H., CHENG, P. Y., SOONG, Y. AND WU, D. L.: Lack of relationship
between opioid-induced changes in fetal breathing and plasma glucose levels. Am. J. Physiol. Regul. Integr. Comp. Physiol. 269: R702–R707, 1995.
